Solid Biosciences LLC

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$4,736
Gross Profit
-1,235
-327
4,149
EBITDA
-23,749
-23,881
-21,678
EBIT
-24,984
-24,208
-22,265
Net Income
-25,072
-24,303
-20,336
Net Change In Cash
0
0
4,736
Free Cash Flow
-21,753
-25,341
-20,913
Cash
95,854
117,574
74,015
Basic Shares
40,934
38,155
20,386

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$0
$8,094
$13,620
$3,335
Gross Profit
-76,563
5,686
-45,119
-3,922
EBITDA
-93,434
-96,866
-69,290
-84,368
EBIT
-96,015
-99,274
-72,254
-88,290
Net Income
-96,015
-65,510
-72,124
-90,118
Net Change In Cash
0
8,094
13,620
3,335
Cost of Revenue
36,011
-33,865
78,701
Free Cash Flow
-95,695
-100,992
-79,045
-57,498
Cash
74,015
155,384
119,136
154,744
Basic Shares
19,884
8,512
7,118
3,462

Earnings Calls

Quarter EPS
2024-09-30
-$0.79
2024-06-30
-$0.61
2024-03-31
-$0.64
2023-12-31
-$1